Antisense oligonucleotides to p53
US5654415A · kind A · utility
1Cited by
0References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 21, 1994 |
| Grant date | Aug 5, 1997 |
| Priority date | — |
| Expiry date | Oct 21, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/315
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antisense oligonucleotides and composition of oligonucleotides are taught which inhibit the proliferation of cells without affecting cell viability. p53 antisense oligonucleotides are shown to inhibit the proliferation of tissue culture cells expressing this gene. Methods of treating a patient with such antisense oligonucleotides is described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.